Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Histology Pathology Managed Service for Berkshire Surrey Pathology Services

  • First published: 05 December 2019
  • Last modified: 05 December 2019
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Frimley Health NHS Foundation Trust
Authority ID:
AA35849
Publication date:
05 December 2019
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The contract agreement will be let for a term of seven (7) years only with the option to extend for further periods, provided that the total term of the agreement does not exceed fourteen (14) years. The awarding authority has established the most economically advantageous tender (‘MEAT’) for the contract for the provision of a pathology managed service for histology. This includes but is not limited to laboratory equipment, maintenance and servicing, all associated consumables; reagents, auxiliary goods and equipment, training with associated services, installation, and enabling works. The contract aims to deliver the vision of BSPS to place pathology at the forefront of healthcare delivery and to bring added value to patients and users.

Growth and innovation are key strategic objectives for BSPS. By growing, we can invest, and by investing we can be innovative. We intend to grow by expanding our repertoire of services and by attracting new customers through what we do and how we do it. We have a strong desire to be innovative. We want to develop ways in which we deliver pathology services that truly are of greater benefit to patients and users (added value) – new ways of accessing tests and results; more meaningful information about diagnosis and how to interpret results; better use of existing and developmental tests to shape care pathways for improved patient and user experience; partnering with organisations to translate novel ideas and research and development activity into practical use for patients and clinicians.

The managed service will be subject to on-going review and development by BSPS to take note of emerging best practice and advances in approach throughout the life of the service. There is a clear expectation that the service provider will work closely with the BSPS and strive to continuously improve service delivery, embrace innovation and provide a flexible service which can readily respond to changing needs.

The provider has demonstrated their understanding of immediate and long term requirements of both the NHS and the pathology industry, with continual improvement and underpinned by best practice. BSPS pathology has sought a partner to help deliver BSPS’s vision to include but not be limited to such services as lean, service improvements, horizon scanning.

The objectives of the new Histology service are:

(a) to deliver leading pathology innovation;

(b) ensure a planned and reactive maintenance programme, that ensures uptime of equipment;

(c) provide a regular service programme on all pathology equipment across all sites comprising BSPS Pathology;

(d) improved logistics and material management on stock control, stock taking, ordering, deliveries;

(e) improved capacity and resilience across all sites;

(f) timely implementation of software and interface upgrades;

(g) maximise the educational, learning and innovation.

This will enable and ensure service provision, expansion and development, supporting the Trusts’ strategic development for the services commissioned and delivered to the customers of BSPS.

The quality expectations of pathology services are increasing and accreditation requirements, both statutory and mandatory, are becoming much more stringent. This will continue and all suppliers will need to assist services in meeting standards as they are implemented. BSPS currently operates a number of quality measures as part of its governance standards and for on-going service quality review. These measures include assessment by external independent assessors against National, European or Quality Management standards including ISO15189, BSQR (2005), HTA, PHE and others. In addition there are an extensive number of operational key performance indicators around service provision including sample turnaround times.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

Frimley Health NHS Foundation Trust

Portsmouth Road

Frimley

GU16 7UJ

UK

Contact person: Please use Bravo Messaging System

Telephone: +44 1276604604

E-mail: david.hurst2@nhs.net

NUTS: UKJ

Internet address(es)

Main address: www.frimleyhealth.nhs.uk

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Histology Pathology Managed Service for Berkshire Surrey Pathology Services

II.1.2) Main CPV code

85111800

 

II.1.3) Type of contract

Services

II.1.4) Short description

Berkshire and Surrey Pathology Services (BSPS) has procured a pathology managed service contract for the services of histology pathology. BSPS is a contractual joint venture between: Ashford and St. Peter’s NHS Foundation Trust, Frimley Health NHS Foundation Trust, Royal Berkshire NHS Foundation Trust, and Royal Surrey County NHS Foundation Trust.

The contract includes but is not limited to: laboratory equipment, maintenance and servicing, all associated consumables; reagents, auxiliary goods and equipment, training with associated services, installation, and enabling works.

Strategic involvement will be expected, to ensure that best value and operational efficiency are achieved and maintained for the Trust throughout the life of the contract.

The awarding authority seeks to award the contract to a single legal entity.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 5 801 440.00  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKJ


Main site or place of performance:

Berkshire and Surrey.

II.2.4) Description of the procurement

The contract agreement will be let for a term of seven (7) years only with the option to extend for further periods, provided that the total term of the agreement does not exceed fourteen (14) years. The awarding authority has established the most economically advantageous tender (‘MEAT’) for the contract for the provision of a pathology managed service for histology. This includes but is not limited to laboratory equipment, maintenance and servicing, all associated consumables; reagents, auxiliary goods and equipment, training with associated services, installation, and enabling works. The contract aims to deliver the vision of BSPS to place pathology at the forefront of healthcare delivery and to bring added value to patients and users.

Growth and innovation are key strategic objectives for BSPS. By growing, we can invest, and by investing we can be innovative. We intend to grow by expanding our repertoire of services and by attracting new customers through what we do and how we do it. We have a strong desire to be innovative. We want to develop ways in which we deliver pathology services that truly are of greater benefit to patients and users (added value) – new ways of accessing tests and results; more meaningful information about diagnosis and how to interpret results; better use of existing and developmental tests to shape care pathways for improved patient and user experience; partnering with organisations to translate novel ideas and research and development activity into practical use for patients and clinicians.

The managed service will be subject to on-going review and development by BSPS to take note of emerging best practice and advances in approach throughout the life of the service. There is a clear expectation that the service provider will work closely with the BSPS and strive to continuously improve service delivery, embrace innovation and provide a flexible service which can readily respond to changing needs.

The provider has demonstrated their understanding of immediate and long term requirements of both the NHS and the pathology industry, with continual improvement and underpinned by best practice. BSPS pathology has sought a partner to help deliver BSPS’s vision to include but not be limited to such services as lean, service improvements, horizon scanning.

The objectives of the new Histology service are:

(a) to deliver leading pathology innovation;

(b) ensure a planned and reactive maintenance programme, that ensures uptime of equipment;

(c) provide a regular service programme on all pathology equipment across all sites comprising BSPS Pathology;

(d) improved logistics and material management on stock control, stock taking, ordering, deliveries;

(e) improved capacity and resilience across all sites;

(f) timely implementation of software and interface upgrades;

(g) maximise the educational, learning and innovation.

This will enable and ensure service provision, expansion and development, supporting the Trusts’ strategic development for the services commissioned and delivered to the customers of BSPS.

The quality expectations of pathology services are increasing and accreditation requirements, both statutory and mandatory, are becoming much more stringent. This will continue and all suppliers will need to assist services in meeting standards as they are implemented. BSPS currently operates a number of quality measures as part of its governance standards and for on-going service quality review. These measures include assessment by external independent assessors against National, European or Quality Management standards including ISO15189, BSQR (2005), HTA, PHE and others. In addition there are an extensive number of operational key performance indicators around service provision including sample turnaround times.

II.2.5) Award criteria

Quality criterion: Strategic / Weighting: 7

Quality criterion: Operational / Weighting: 45

Quality criterion: Estates / Weighting: 3

Quality criterion: Transitional / Weighting: 5

Cost criterion: Price / Weighting: 36

Cost criterion: Terms and conditions / Weighting: 3

Cost criterion: Compensation on termination / Weighting: 1

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Restricted procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2016/S 194-348997

IV.2.9) Information about termination of call for competition in the form of a prior information notice

The contracting authority will not award any further contracts based on the above prior information notice

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

29/10/2019

V.2.2) Information about tenders

Number of tenders received: 2

Number of tenders received by electronic means: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Roche Diagnostics Ltd

Burgess Hill

RH15 9RY

UK

NUTS: UKJ28

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 5 801 440.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

Frimley Health NHS Foundation Trust

Frimley

UK

VI.4.2) Body responsible for mediation procedures

Frimley Health NHS Foundation Trust on behalf BSPS

Frimley

UK

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

Frimley Health NHS Foundation Trust will incorporate a voluntary standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into the Public Contracts Regulations 2015 provide for aggrieved parties who have been harmed or are at risk of harm by a breach of the rules to take action in the High Court (England, Wales and Northern Ireland).

VI.5) Date of dispatch of this notice

03/12/2019

Coding

Commodity categories

ID Title Parent category
85111800 Pathology services Hospital services

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
david.hurst2@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.